Thrombolytic therapy in patients with acute ischemic or hemorrhagic stroke
DOI:
https://doi.org/10.25305/unj.130882Keywords:
cerebrovascular accident, fibrinolysis, plasminogen activatorsAbstract
The main mechanisms of thrombolytic drugs’ effects, and their comparative analysis are presented.
Advantages and disadvantages of plasminogen activator for acute ischemic stroke treatment, hypertensive intracerebral hematomas, intraventricular hemorrhages are demonstrated.
References
Братчик А.М. Клинические проблемы фибринолиза. — К.: Здоровья. — 1993. — 344 с.
Буров С.А., Ситников А.Р. Использование прямых тромболитиков при интравентрикулярных кровоизлияниях, обусловленных разрывами аневризм и артерио-венозных мальформаций // Нейрохирургия. — 2004. — №3. — С. 51–55.
Крылов В.В. Гидроцефальный синдром при нетравматических внутричерепных кровоизлияниях // Нейрохирургия. — 2000. — №1 — 2. — С. 72.
Крылов В.В., Буров С.А., Галанкина И.Е., Дашьян В.Г. Локальный фибринолиз в хирургии внутричерепных кровоизлияний // Нейрохирургия. — 2006. — №3. — С. 4–12.
Крылов В.В., Буров С.А., Дашьян В.Г. Тромболизис в неотложной нейрохирургии. // Здравоохранение и мед. техника. — 2004. — № 10 (14). — С. 24–25.
Крылов В.В., Буров С.А., Талыпов А.Э., Гунба Д.Д. Возможности применения стрептокиназы для хирургического лечения травматических внутричерепных гематом // Нейрохирургия. — 2004. — №4. — С. 15–21.
Крылов В.В., Дашьян В.Г. Выбор метода хирургического лечения гипертензивных гематом // Нейрохирургия. — 2005. — №2. — С. 10–16.
Лебедев В.В., Крылов В.В., Холодов С.А. Хирургия аневризм головного мозга в остром периоде кровоизлияния. — М.: Медицина. — 1996. — 255 с.
Максименко А.В., Тищенко Е.Г. Комбинированный тромболизис - новое направление исследования активаторов плазминогена третьего поколения // Вопр. биол. мед. и фармакол. химии. — 2000. — №1. — С. 1–10.
Максименко А.В., Тищенко Е.Г., Добровольский А.Б. Стратегия тромболиза: сочетаное действие активаторов плазминогена. Тромболитические композиции // Хим.-фарм. журн. — 1998. — Т. 32, №4. — С. 12–13.
Панченко Е.П. Тромболитические средства. Часть 3. // Клин. фармакология и терапия. — 1998. — №7. — С.84–88.
Петрищев Н.Н., Папаян Л.П. Гемостаз. — СПб.: СПбГМУ. — 1999. — 117 с.
Рожченко Л.В. Тромболитическая терапия в современной нейрохирургической практике // Российский нейрохирургический институт им. проф. А.Л. Поленова. http: //www. neuro. neva. Ru /Russian/ Issues/ Articles_3_2001/ rozhchenko.htm
Сарибекян А.С., Полякова Л.И. Пункционная аспирация гипертензивных гематом с использованием локального фибринолиза // Материалы II Съезда нейрохирургов Российской Федерации. — Н. Новгород, 1998. — С. 193–194.
Сарибекян А.С., Полякова Л.Н. Результаты хирургического лечения больных с гипертензивными внутримозговыми гематомами пункционно-аспирационным способом в сочетании с локальным фибринолизом проурокиназой // Вопр. нейрохирургии. — 2003. — №3. — С.8–11.
Яворская В.А., Фломин Ю.В., Дьолог Н.В., Гребенюк А.В. Тромболитическая терапия при инсульте // Харьковская медицинская академия последипломного образования, Харьковский городской центр цереброваскулярной патологии, Харьковская городская клиническая больница №7. http://www.health-ua.org/article/health/1046.html
Brinker T., Seifert V., Dietz H. Subacute hydrocephalus after experimental subarachnoid hemorrhage: its prevention by intrathecal fibrinolysis with recombinant tissue plasminogen activator // J. Neurosurg. — 1992. — N31. — Р. 301–311.
Brott T.G., Halcy E.C. Jr., Levy D.F. et al. Urgent therapy for stoke. I: pilot study of tissue plasminogen activator administration within 90 minute // Stroke. — 1992. — N23. — P.632–640.
Cronqvist M., Pierot L., Boulin A. et al. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: A comparison of anatomic results and clinical outcome // Am. J. Neuroradiol. — 1998. — N19. — Р.157–165.
Del Zoppo G.J. Thrombolytic therapy in treatment of stroke // Drugs. — 1997. V.54, N3. — P.90–99.
Donauer E., Reif J., Al-Khalaf B. et al. Intraventricular hemorrhage caused by aneurysms and angiomas // Acta Neurochir. — 1993. — V.122. — P.23–31.
Ekseth K., Bostrom S. Reversibility of severe sagital sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: technical case report // J. Neurosurg. — 1998. — V.43, N4. — P.960–965.
Findlay J.M., Kassell N.F., Weir B.K.A. et al. A randomized trial of intra-operative, intracisternal tissue plasminogen activator for the prevention of vasospasm // J. Neurosurg. — 1995. — V.37. — P.168–178.
Goh K.Y.C., Poon W.S. Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage // Surg. Neurol. — 1998. — V.50. — P.526–532.
Grabhb P.A. Traumatic intraventricular hemorrhage activator: technical case report // J. Neurosurg. — 1998. — V.43. — P.966–969.
Griesemen D.A., Treodorou A.A., Berg R.A., Spera T.D. Local fibrinolysis in cerebral venous thrombosis // Pediatr. Neurol. — 1994. — V.10, N1. — P.78–80.
Hanley D., Hacke W. Critical care and emergency medical neurology in stroke // Stroke. — 2005. — V.36. — P.205–207.
Hijdra A., Van Gijn J. Early death from rupture of an intracranial aneurysm // J. Neurosurg. — 1982. — V.57. — P.765–768.
Horowitz MB, Purdy P. Unwin H: Treatment of dural sinus thrombosis using selective catheterization and urokinase // Ann Neurol. — 1995. — N38. — P.58–67.
Ikeda K., Asakura H., Futami K. Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage // J. Neurosurg. — 1997. — V.41, N2. — P.344–350.
Itoh S., Sasaki T., Asai A., Kuchino Y. Prevention of delayed vasospasm by an endothelin ETA, receptor antagonist. BQ-123 change in ETA receptor mRNA expression in a canine subarachnoid hemorrhage model // J. Neurosurg. — 1994. — N81. — P.759–764.
Jahan R., Duckwiler G.R., Kidwell C.S. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow up // Am. J. Neuroradiol. — 1999. — N20. — P.1291–1299.
Kayimoto Y., Ohta T. Comparison of intrathecally administered urokinase, tissue-type plasminogen activatir, and combination of urokinase and lysine plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs // J. Newrosurg. — 1997. — V.40. –N3. — P.572–577.
Kim M.N., Kim E.Y., Song J.H., Shin K.M. Surgical options of hypertensive intracerebral hematoma: stereotactic endoscopic removal versus catheter drainage // J. Korean Med. Sci. — 1998. — V.13, (N5). — P.533–540.
Liang J.F., Li Y., Yand V.C. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation // Tromb. Res. — 2000. — V.197, N5. — P.439–458.
Matsumoto K., Hondo H. CT-guided stereotactic evacuation of hypertensive intracerebral hematomas // J. Neurosurg. — 1984. — V.61. — P.440–448.
Mizoi K., Yoshimoto T., Fujiwara S. et al. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator. Preliminary report // J. Neurosurg. — 1991. — N28. — P.807–813.
Mizoi K., Yoshimoto T., Takahashi A. et al. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator // J. Neurosurg. — 1993. — N78. — P.430–437.
Neuhaus K.L., Feuerer W., Jeep-Tebbe S. et al. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator // J. Am. Coil. Cardiol. — 1989. — N14. — Р.1566–1569.
Niewkamp D.J., de Gansk., Renkelg J. Treatment and outcame of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: systematic review of the literature // J. Neurol. — 2000. — V.247. — P.117–121.
Ohman J., Servo A., Heiskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage // J. Neurosurg. — 1991. — N75. — P.197–201.
Qureshi A.I., Luft A.R., Sharna M. Intraarterial tissue plasminogen activator for ischemic stoke: an acceleration dosing regimen // J. Neurosurg. — 2000. — V.47, N2. — P.1140–1145.
Qureshi A.I., Luft A.R., Sharna M. et al. Prevention and treatment of tromboembolic and ischemic complications associated with endovacular procedures: Part I. Pathophysiological and pharmacological features // J. Neurosurg. — 2000. — V.46, N6. — P.1344–1359.
Rohde V., Schaller C., Hassler W.E. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular hemorrhage // J. Neurol. Neurosurg. Psychiatry. — 1995. — N58. — P.447–451.
Schutz H. Intracerebral hemorrhage // Ther. Umsch. — 1996. — Bd.53, H7. — S.590–596.
Scott J.A., Pascuzzi R.M., Hall P.V., Becker G.L. Treatment of dural sinus thrombosis with local urokinase infusions // J. Neurosurg. — 1988. — N68. — P.284–287.
Seifert V., Eisert W.C., Stoike D., Coetz C. Efficacy of single intra cisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage // J. Neurosurg. — 1989. — N25. — P.590–598.
Steiger H.J. Surgical therapy of intracerebral hemorrhages // Ther. Umsch. — 1996. — Bd.53, H7. — S.597–599.
Stopke D., Seifert V. Single intracistemal bolus injection of recombinant tissue plasminogen activator (rtPA) in patients with aneurysmal subarachnoid hemorrhage: Preliminary assessment of efficacy and safety in an open clinical study // J. Neurosurg. — 1992. — N30. — P.877–881.
Teernstra O.P., Evers S.M., Lodder J. et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA) // Stroke. — 2003. — V.34, N4. — P.968–974.
Treggiary-Venzi M.M., Sutery H.M., Romand Y.A. Rewiev of medical prevention of vasospasm after aneurysmal subarachnoid: A problem of Neurointensive Care // J. Neurosurg. — 2001. — V.48. — N2. — P.249–262.
Ujnen H.R., Collen D. Fibrinolytic agents: Mechanisms of activity and pharmacology // Thromb. Haemost. — 1995. — N74. — Р.387–390.
Usui M., Saito N., Hoya K., Todo T. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: A retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone // J. Neurosurg. — 1994. — V.34. — P.235–245.
Whitelaw A. Intraventricular streptokinase after intraventricular hemorrhage in newborn infants // http://www.nichd.nih.gov/COCHRANE/Whitela2/Whitelaw.htm
Yoshida Y., Ueki S., Takahashi A. et al. Intrathecal irrigation with urokinase in ruptured cerebral aneurysm cases // Neurol. Med. Chir. (Tokyo). — 1985. — V.25. — P.989–997.
Zabramski J.M., Spetzler R.F., Lee K.S. et al. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurismal subarachnoid hemorrhage // J. Neurosurg. — 1991. — N75. — P.189–196.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2007 O. A. Tsimeyko, M. V. Berezyuk, V. V. Moroz, I. I. Skorokhoda, N. Shahin
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
